z-logo
Premium
Quercetin Prevents UV‐lnduced Local Immunosuppression, but Does Not Affect UV‐lnduced Tumor Growth in SKH‐1 Hairless Mice
Author(s) -
Steerenberg P.A.,
Dortant J. Garsser V.P.,
Vliet H.,
Geerse L.,
Verlaan A. P. J.,
Goettsch W.,
Sontag Y.,
Norval M.,
Gibbs N. K.,
BuenodeMesquita H. B.,
Loveren H. Van
Publication year - 1997
Publication title -
photochemistry and photobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.818
H-Index - 131
eISSN - 1751-1097
pISSN - 0031-8655
DOI - 10.1111/j.1751-1097.1997.tb01918.x
Subject(s) - hairless , immunosuppression , affect (linguistics) , quercetin , chemistry , cancer research , medicine , photochemistry , psychology , biochemistry , communication , antioxidant
— Ultraviolet is thought to induce skin tumors by its dual activity as a mutagenic agent and a suppressor of cell‐mediated immunity. In the present study the effects of quercetin, a flavonoid‐containing compound, on carcinogenesis and immunosuppression were studied in SKH hairless mice exposed to suberythemal doses of UV for up to 17 weeks. It was found that quercetin did not affect the onset or growth of non‐melanoma skin tumors resulting from UV exposure. In contrast, it prevented the suppression in contact hypersensitivity (CHS) to picryl chloride induced by UV. The mechanism of this prevention might be explained by the observation that the decreased number of epidermal Langerhans'cells is partly prevented by the quercetin. Quercetin did not alter the effects of UV in increasing numbers of spleen and lymph node cells, only partly in decreasing the CD8‐positive cells in spleen cell populations and decreasing the lym‐phoproliferative response of spleen cells to the mitogens concanavalin A and phytohemagglutinin. Thus oral quercetin did not prevent UV‐induced carcinogenesis although it restored the skin‐associated CHS response probably by protecting the antigen‐presenting cells in the skin.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here